Table 2.
Pathology characteristics for Mexican patients with endometrial carcinoma.
| Characteristic | Patients | Percentage |
|---|---|---|
| Stage FIGO 1988 | ||
| IA | 46 | 11.2 |
| IB | 96 | 23.3 |
| IC | 79 | 19.2 |
| IIA | 44 | 10.7 |
| IIB | 42 | 10.2 |
| IIIA | 47 | 11.4 |
| IIIB | 1 | .2 |
| IIIC | 55 | 13.3 |
| IVA | 2 | .5 |
| Grade | ||
| 1 | 165 | 40 |
| 2 | 115 | 27.9 |
| 3 | 130 | 31.6 |
| NOS | 2 | 0.5 |
| Lymphovascular invasion | ||
| Yes | 57 | 13.8 |
| No | 341 | 82.8 |
| NOS | 14 | 3.4 |
| Number of nodes | ||
| None | 168 | 40.8 |
| 1−10 | 181 | 43.9 |
| 11– 20 | 51 | 12.4 |
| 21– 30 | 4 | 1.0 |
| 31– 40 | 8 | 1.9 |
| Mean of nodes obtained at surgery | 5 (1–40) | |
| Histology | ||
| Endometrioid | 359 | 87.1 |
| Papillary serous | 21 | 5.1 |
| Clear cell | 10 | 2.4 |
| Adenosquamous | 21 | 5.1 |
| Glassy cell | 1 | .2 |
| Size | ||
| <3 cm | 66 | 16.0 |
| 3 −5.9 cm | 100 | 24.3 |
| >6 cm | 77 | 18.7 |
| NOS | 169 | 41.0 |
| Mean size (cm) | 4.78 (0.3–20.5) | |
| Isthmus invasion | ||
| Present | 76 | 18.4 |
| Absent | 336 | 81.6 |
| Uterine cervix involvement | ||
| Endocervical gland | 52 | 12.6 |
| Stromal | 94 | 22.8 |
| None | 266 | 64.6 |
| Serous Involvement | ||
| Present | 47 | 11.4 |
| Absent | 365 | 88.6 |
| Positive peritoneal washing | ||
| Present | 16 | 3.9 |
| Absent | 352 | 85.4 |
| NOS | 44 | 10.7 |
| Adnexial involvement | ||
| Present | 38 | 9.2 |
| Absent | 374 | 90.8 |
| Number of positive nodes | ||
| 1 | 19/412 | 4.6 |
| 2 | 9/412 | 2.2 |
| 3 | 6/412 | 1.5 |
| >3 | 9/412 | 2.2 |
| Myometrial invasion | ||
| <1/2 | 138 | 33.5 |
| >1/2 | 221 | 53.6 |
| None | 49 | 11.9 |
| NOS | 4 | 1.0 |
| Para aortic node involvement | ||
| Present | 17 | 4.1 |
| Absent | 395 | 95.9 |
| Pelvic node involvement | ||
| Present | 39 | 9.5 |
| Absent | 373 | 90.5 |
| Risk categories | ||
| Low | 99 | 24.0 |
| Low-intermediate | 55 | 13.3 |
| High intermediate | 47 | 11.4 |
| High | 211 | 51.2 |
NOS: not otherwise specified.